Based in Waltham, MA, the process development and manufacturing site covers 30,000 sq ft. A current good manufacturing practice (cGMP) suite will house 500-L microbial and 2,000-L mammalian bioreactors. The facility will also have process, analytical method development, and quality control labs supporting local and international customer projects. The company, formerly known as Northway Biotechpharma, said that it plans to offer end-to-end services for biologics, with the goal of being fully operational in the fourth quarter.

The company has a manufacturing plant in Vilnius, Lithuania. The Waltham, MA, site is the company's first manufacturing site in the U.S. and second globally. The new location entailed a capital investment of $40 million, the company noted.

Tackling the next hurdle in cell and gene therapy: Manufacturing
Although innovation continues to occur at lightning fast speeds in the cell and gene therapy space, commercialization and manufacturing of these technologies...

Fujifilm Diosynth to establish viral vector manufacturing in Boston
Contract development and manufacturing organization Fujifilm Diosynth Biotechnologies will establish a new process development and manufacturing facility...

Eurofins CDMO expands drug product operations in Canada
Eurofins contract development and manufacturing organization (CDMO) has expanded its existing drug product operation capabilities with a new manufacturing...